Oxford Cannabinoid Technologies Holdings Plc

LSE:OCTP Stock Report

Market Cap: UK£1.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oxford Cannabinoid Technologies Holdings Management

Management criteria checks 1/4

Oxford Cannabinoid Technologies Holdings' CEO is Clarissa Sowemimo-Coker, appointed in Dec 2022, has a tenure of 1.5 years. total yearly compensation is £215.67K, comprised of 90% salary and 10% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth £2.87K. The average tenure of the management team and the board of directors is 1.5 years and 2.2 years respectively.

Key information

Clarissa Sowemimo-Coker

Chief executive officer

UK£215.7k

Total compensation

CEO salary percentage90.0%
CEO tenure1.5yrs
CEO ownership0.2%
Management average tenure1.5yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Clarissa Sowemimo-Coker's remuneration changed compared to Oxford Cannabinoid Technologies Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2023n/an/a

-UK£4m

Jul 31 2023n/an/a

-UK£5m

Apr 30 2023UK£216kUK£194k

-UK£6m

Apr 30 2022UK£194kUK£174k

-UK£5m

May 31 2021n/an/a

-UK£3m

Compensation vs Market: Clarissa's total compensation ($USD275.64K) is about average for companies of similar size in the UK market ($USD355.60K).

Compensation vs Earnings: Clarissa's compensation has increased whilst the company is unprofitable.

CEO

Clarissa Sowemimo-Coker (44 yo)

1.5yrs

Tenure

UK£215,669

Compensation

Ms. Clarissa Ann Sowemimo-Coker serves as Chief Executive Officer at Oxford Cannabinoid Technologies Holdings Plc since April 12, 2023 and is its Executive Director since February 4, 2021. She was its Comp...

Leadership Team

NamePositionTenureCompensationOwnership
Clarissa Sowemimo-Coker
CEO & Executive Director1.5yrsUK£215.67k0.23%
£ 2.9k
Indraneil Mahapatra
Co-Founder & Non-Executive Directorno dataUK£25.00k1.96%
£ 24.5k
Paul Smalley
Finance Director & Executive Director1.7yrsUK£155.16kno data
Valentino Parravicini
Chief Scientific Officer3.9yrsno datano data
Robin Bennett
General Counsel & Company Secretary1.5yrsno data0.030%
£ 380.6
Timothy Corn
Executive Director & Chief Medical Officerless than a yearno datano data

1.5yrs

Average Tenure

51yo

Average Age

Experienced Management: OCTP's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Clarissa Sowemimo-Coker
CEO & Executive Director3.3yrsUK£215.67k0.23%
£ 2.9k
Indraneil Mahapatra
Co-Founder & Non-Executive Director3.3yrsUK£25.00k1.96%
£ 24.5k
Paul Smalley
Finance Director & Executive Director1.7yrsUK£155.16kno data
Timothy Corn
Executive Director & Chief Medical Officerless than a yearno datano data
Julie Pomeroy
Independent Non-Executive Chair3.2yrsUK£45.00k0.060%
£ 747.5
Robert Dworkin
Member of Scientific Advisory Board2.2yrsno datano data
Charanjit Dhillon
Senior Independent Non-Executive Director3.2yrsUK£25.00kno data
Giorgio Lambru
Member of Scientific Advisory Board2.2yrsno datano data
Anthony Dickenson
Member of Scientific Advisory Board2.2yrsno datano data
Darren Mott
Independent Non-Executive Directorless than a yearno datano data
William Farquhar-Smith
Member of Scientific Advisory Boardno datano datano data

2.2yrs

Average Tenure

51yo

Average Age

Experienced Board: OCTP's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/06 05:47
End of Day Share Price 2024/06/06 00:00
Earnings2023/10/31
Annual Earnings2023/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oxford Cannabinoid Technologies Holdings Plc is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Soo RomanoffEdison Investment Research